SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950103-19-004949
Filing Date
2019-04-19
Accepted
2019-04-19 17:07:55
Documents
6
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A dp105140_20fa.htm 20-F/A 26779
2 EXHIBIT 4.14 dp105140_ex0414.htm EX-4.14 536140
3 EXHIBIT 12.1 dp105140_ex1201.htm EX-12.1 6293
4 EXHIBIT 12.2 dp105140_ex1202.htm EX-12.2 6488
5 GRAPHIC image_001.jpg GRAPHIC 2119
6 GRAPHIC image_002.jpg GRAPHIC 2907
  Complete submission text file 0000950103-19-004949.txt   583905
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-37891 | Film No.: 19758260
SIC: 2834 Pharmaceutical Preparations